Frazier Life Sciences
Venture Capital
Biotech investment firm with venture and public strategies partnering with and building companies developing novel therapeutics.
Growth
Late Stage
Early Stage
Biotech
Life Sciences
- Headquarters
- Palo Alto, United States
- Founded
- 2015
- Website
- frazierls.com
- AUM
- $5
- Last Investment
- Jan 2026
- Geographic Focus
- United States, Europe
Investment Thesis
Manages venture capital for early-stage biopharma company creation and Series A, and public equity in biopharmas with novel therapeutics across oncology and orphan diseases.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account